Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults
NCT02478281
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Methemoglobinemia
Congenital Methemoglobinemia
Interventions
DRUG:
Methylene Blue
Sponsor
American Regent, Inc.